Skip to main content

Advertisement

SpringerLink
Log in

Is Systemic Inflammation Not Involved in Endoscopic Duodenal-Jejunal Bypass Liner-Induced Diabetes Remission?

  • Letter to the Editor
  • Published:
Obesity Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. de Jonge C, Rensen SS, D’Agnolo HM, et al. Six months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 diabetes. Obes Surg. 2014;24(2):337–41.

    Article  PubMed  Google Scholar 

  2. Carstensen M, Herder C, Kivimäki M, et al. Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study. Diabetes. 2010;59(5):1222–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Herder C, Brunner EJ, Rathmann W, et al. Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study. Diabetes Care. 2009;32(3):421–3.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007;356(15):1517–26.

    Article  PubMed  CAS  Google Scholar 

  5. Larsen CM, Faulenbach M, Vaag A, et al. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care. 2009;32(9):1663–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Glas R, Sauter NS, Schulthess FT, et al. Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival. Diabetologia. 2009;52(8):1579–88.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Chen CY, Lee WJ, Asakawa A, et al. Insulin secretion and interleukin-1b dependent mechanisms in human diabetes remission after metabolic surgery. Curr Med Chem. 2013;20(18):2374–88.

    Article  PubMed  CAS  Google Scholar 

  8. de Jonge C, Rensen SS, Verdam FJ, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg. 2013;23(9):1354–60.

    Article  PubMed  Google Scholar 

  9. Chen CY, Fujimiya M, Laviano A, et al. Modulation of ingestive behavior and gastrointestinal motility by Ghrelin in diabetic animals and humans. J Chin Med Assoc. 2010;73(5):225–9.

    Article  PubMed  CAS  Google Scholar 

  10. Suzuki H, Asakawa A, Amitani H, et al. Cachexia and herbal medicine: perspective. Curr Pharm Des. 2012;18(31):4865–88.

    Article  PubMed  CAS  Google Scholar 

  11. Lee WJ, Chen CY, Ser KH, et al. Differential influences of gastric bypass and sleeve gastrectomy on plasma nesfatin-1 and obestatin levels in patients with type 2 diabetes mellitus. Curr Pharm Des. 2013;19(32):5830–5.

    Article  PubMed  CAS  Google Scholar 

  12. Chen CY, Tsai CY, Lee WJ, et al. Intracerebroventricular O-n-octanoylated ghrelin and its splice variant-induced feeding is blocked by insulin, independent of obestatin or CRF receptor, in satiated rats. Nutrition. 2012;28(7–8):812–20.

Download references

Acknowledgments

This paper was partly sponsored by a grant from Taipei Veterans General Hospital, Taipei, Taiwan (V101C-118).

Conflict of Interest

None.

Author information

Authors and Affiliations

  1. Department of Medicine, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei, 112, Taiwan, Republic of China

    Cheng-I Wu

  2. Department of Surgery, Min-Sheng General Hospital, Taoyuan, Taiwan

    Wei-Jei Lee

  3. Taiwan Society for Metabolic and Bariatric Surgery, Taoyuan, Taiwan

    Wei-Jei Lee

  4. Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei, 112, Taiwan, Republic of China

    Chih-Yen Chen

  5. Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan

    Chih-Yen Chen

Authors
  1. Cheng-I Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei-Jei Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chih-Yen Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chih-Yen Chen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, CI., Lee, WJ. & Chen, CY. Is Systemic Inflammation Not Involved in Endoscopic Duodenal-Jejunal Bypass Liner-Induced Diabetes Remission?. OBES SURG 24, 2001–2002 (2014). https://doi.org/10.1007/s11695-014-1399-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-014-1399-3

Keywords

Search

Navigation